Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes
about
Perspectives on reprograming cancer-associated dendritic cells for anti-tumor therapiesToll-like Receptors in Ovarian Cancer as Targets for ImmunotherapiesImmunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancerAnti-tumor immunity: myeloid leukocytes control the immune landscapeImmunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor.Sensitization of ovarian carcinoma cells with zoledronate restores the cytotoxic capacity of Vγ9Vδ2 T cells impaired by the prostaglandin E2 immunosuppressive factor: implications for immunotherapy.Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.CD277 is a negative co-stimulatory molecule universally expressed by ovarian cancer microenvironmental cells.Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor growth whereas MSC2-treatment promotes tumor growth and metastasis.Interactome analysis of myeloid-derived suppressor cells in murine models of colon and breast cancerImmunity and immune suppression in human ovarian cancer.Recent progress in targeting cancer.Modulating the tumor immune microenvironment as an ovarian cancer treatment strategy.The immune system in the pathogenesis of ovarian cancer.In vivo immune cell distribution of gold nanoparticles in naïve and tumor bearing mice.Harnessing the effect of adoptively transferred tumor-reactive T cells on endogenous (host-derived) antitumor immunity.The tumor microenvironment: part 1.Dendritic cells and their role in tumor immunosurveillance.Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts.Good things come in small packages: Therapeutic anti-tumor immunity induced by microRNA nanoparticles.VEGF Potentiates GD3-Mediated Immunosuppression by Human Ovarian Cancer Cells.Inhibition of Ovarian Tumor Growth by Targeting the HU177 Cryptic Collagen Epitope.Reprogramming immune responses via microRNA modulation.Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer
P2860
Q26830839-F451A461-DB58-4736-BC00-3018B0CF8C44Q26861234-F0C5B546-F546-4370-B30D-EA376EB0C54BQ26996829-064E1D2F-4A16-424F-813C-2ED4EC30380AQ28390573-D45E1862-7F89-4DB7-BA9E-EA748321EA08Q33750160-25588709-AF29-4DBA-A5C8-0731AF69B6AAQ34077388-B4E91EEC-D701-440F-BC46-8CD5F453A35CQ34307356-2646F64A-B064-41BD-9CB6-22E798D5D90EQ34352531-CFBDDA75-85F4-46C1-B6D7-8764DE71FA19Q34429538-FB9D6A1D-BE34-41A3-86E1-362E81FE0071Q34956969-C072BB1B-B0B7-4486-A814-429E5D0C3FE0Q35138135-65D0214F-5E89-4A1C-AB6B-A2B3FCF19FBAQ35740782-E9305366-1476-451E-B9CE-985CF4D0D8EFQ37169908-03C81BB9-6650-438F-A689-92FB1BA411AAQ37613407-23610657-8961-4022-920F-F509D6B5DFEDQ37656558-F29F76CC-938B-43CB-9669-E23E43392DCDQ37809463-A20ABE2E-EAEF-44CF-B254-4CDDAE7C3B8CQ37952794-1624E6B4-8672-4A30-94DA-C94416A7DBA9Q38021625-3F4BDD45-9ED7-401B-A821-1B79AF345C68Q39098568-2267B8B8-BA62-4F86-BD14-4971C3B24366Q41474711-9320279F-8A6A-43AA-A195-885BC80299B9Q41738853-812B10F3-5F1B-4B5E-8E73-25D8E82731AFQ42735424-8CB7BB94-73FF-496B-A7BD-40135ACAFDFCQ42925805-4E8E83C1-7494-46E5-8AA5-0E0231D9C484Q58423073-42FE9203-8755-4BED-9039-B4B72B11896B
P2860
Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes
@ast
Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes
@en
Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes
@nl
type
label
Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes
@ast
Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes
@en
Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes
@nl
prefLabel
Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes
@ast
Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes
@en
Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes
@nl
P2093
P2860
P356
P1433
P1476
Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes
@en
P2093
Jose R Conejo-Garcia
Juan R Cubillos-Ruiz
Melanie Rutkowski
P2860
P304
P356
10.4161/CC.9.2.10430
P577
2010-01-26T00:00:00Z